Jane Pritchett Henderson - 11 May 2023 Form 4 Insider Report for IVERIC bio, Inc.

Role
Director
Signature
/s/ Todd D.C. Anderman, as Attorney-in-Fact for Jane P. Henderson
Issuer symbol
N/A
Transactions as of
11 May 2023
Net transactions value
$0
Form type
4
Filing time
15 May 2023, 16:47:22 UTC
Previous filing
03 Jun 2022
Next filing
19 May 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISEE Common Stock Options Exercise +14,588 +195% 22,088 11 May 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISEE Restricted Stock Units Options Exercise $0 -14,588 -100% $0.000000* 0 11 May 2023 Common Stock 14,588 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
F2 In accordance with the Registrant's Non-Employee Director Compensation Policy, the Reporting Person was granted 14,588 of the Registrant's restricted stock units on May 12, 2022. Subject to the Reporting Person providing continued services to the Registrant and other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units vested in full one business day prior to the first anniversary of the grant date.